Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:15 pm Sale |
2024-09-30 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Lind Global Fund II LP | 0 0.000% |
-156,250 (Position Closed) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | ASLAN Pharmaceuticals Limited ASLN |
K2 HealthVentures Equity Trust LLC | 61,535,383 9.990% |
58,726,924 (+2091.07%) |
Filing History |
| 2024-08-08 11:36 am Unchanged |
2024-06-30 | 13G | ASLAN Pharmaceuticals Limited ASLN |
UBS Group AG | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-03-21 4:42 pm Purchase |
2024-03-12 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Mitchell P. Kopin | 3,125,000 4.400% |
3,125,000 (New Position) |
Filing History |
| 2024-03-19 4:30 pm Purchase |
2024-03-14 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Lind Global Fund II LP | 156,250 5.700% |
156,250 (New Position) |
Filing History |
| 2024-02-14 4:45 pm Purchase |
2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
K2 HealthVentures Equity Trust LLC | 2,808,459 5.200% |
2,808,459 (New Position) |
Filing History |
| 2024-02-14 10:22 am Purchase |
2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
BIOTECHNOLOGY VALUE FUND L P | 5,418,122 9.990% |
5,418,122 (New Position) |
Filing History |
| 2024-02-06 10:38 am Purchase |
2024-02-06 | 13G | ASLAN Pharmaceuticals Limited ASLN |
UBS Group AG | 2,114,700 8.910% |
2,114,700 (New Position) |
Filing History |
| 2024-01-02 4:00 pm Sale |
2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TANG CAPITAL PARTNERS LP | 766,872 1.500% |
-4,877,526 (-86.41%) |
Filing History |
| 2023-07-13 4:57 pm Purchase |
2023-07-11 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TANG CAPITAL PARTNERS LP | 5,644,398 11.000% |
5,644,398 (New Position) |
Filing History |
| 2023-03-20 5:20 pm Purchase |
2023-02-24 | 13G | ASLAN Pharmaceuticals Limited ASLN |
K2 HealthVentures Equity Trust LLC | 3,308,266 6.200% |
3,308,266 (New Position) |
Filing History |
| 2023-03-06 5:10 pm Purchase |
2023-02-24 | 13G | ASLAN Pharmaceuticals Limited ASLN |
BIOTECHNOLOGY VALUE FUND L P | 1,061,000 9.990% |
1,061,000 (New Position) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TANG CAPITAL PARTNERS LP | 670,616 7.800% |
670,616 (New Position) |
Filing History |
| 2023-02-14 10:24 am Sale |
2022-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
RTW Investments, LP | 0 0.000% |
-406,250 (Position Closed) |
Filing History |
| 2022-04-21 4:00 pm Purchase |
2022-04-11 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TANG CAPITAL MANAGEMENT LLC | 469,903 5.400% |
469,903 (New Position) |
Filing History |
| 2022-02-14 08:53 am Purchase |
2021-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
RTW Investments, LP | 406,250 6.800% |
406,250 (New Position) |
Filing History |
| 2021-02-11 06:04 am Purchase |
2020-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TEMASEK HOLDINGS LTD | 219,057 4.600% |
9,297 (+4.43%) |
Filing History |